Literature DB >> 15960144

Lower serum magnesium levels are associated with more rapid decline of renal function in patients with diabetes mellitus type 2.

P C T Pham1, P M T Pham, P A T Pham, S V Pham, H V Pham, J M Miller, N Yanagawa, P T T Pham.   

Abstract

AIMS: Hypomagnesemia has been implicated in adversely affecting diabetic complications. This is a retrospective study designed to determine whether there is any association between serum magnesium concentration [Mg2+] and the rate of renal function deterioration, as determined by the slope of serum creatinine reciprocals versus time (1/SCr-vs-t), in patients with diabetes mellitus type 2 (DM2).
MATERIALS AND METHODS: DM2 patients without known kidney disease seen at Olive View-UCLA Medical Center for any reason during January-March 2001 were included. For each patient, all available data from our electronic database for [Mg2+], hemoglobin A(1C) (HbA(1C), serum creatinine (SCr), lipid profiles, routine urinary analysis, as well as history of hypertension and pharmacy profiles were retrieved. The average of all parameters obtained and linear regression analyses for the slope of 1/SCr-vs-t plot were performed for each patient. Patients were stratified by gender and divided into four groups based on increasing [Mg2+]. Correlations between each parameter including the slope of 1/SCr-vs-t and the four magnesium groups were analyzed.
RESULTS: 252 males and 298 females with a mean follow-up of 62.6 +/- 22.5 months were included. Patients belonging to lower [Mg2+] groups for both genders had significantly worse slopes of 1/SCr-vs-t plot independent of the presence of hypertension and use of ACEI/ARB, diuretics, HMG-CoA enzyme inhibitors or aspirin. In a multivariate regression analysis controlling for age, HbA(1C) and various components of the lipid profile, [Mg2+] remained an independent predictor for the slope of 1/SCr-vs-t. A trend for worse proteinuria based on routine urinary analysis was observed among patients belonging to the lowest [Mg2+] group.
CONCLUSIONS: Lower [Mg2+] is associated with a faster renal function deterioration rate in DM2 patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15960144     DOI: 10.5414/cnp63429

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  32 in total

1.  Proton Pump Inhibitors and Risk of Incident CKD and Progression to ESRD.

Authors:  Yan Xie; Benjamin Bowe; Tingting Li; Hong Xian; Sumitra Balasubramanian; Ziyad Al-Aly
Journal:  J Am Soc Nephrol       Date:  2016-04-14       Impact factor: 10.121

2.  Low serum magnesium is associated with faster decline in kidney function: the Dallas Heart Study experience.

Authors:  Silvia Ferrè; Xilong Li; Beverley Adams-Huet; Naim M Maalouf; Khashayar Sakhaee; Robert D Toto; Orson W Moe; Javier A Neyra
Journal:  J Investig Med       Date:  2019-03-02       Impact factor: 2.895

Review 3.  Risks of rapid decline renal function in patients with type 2 diabetes.

Authors:  Yi-Jing Sheen; Wayne Hh Sheu
Journal:  World J Diabetes       Date:  2014-12-15

Review 4.  Diabetes mellitus and electrolyte disorders.

Authors:  George Liamis; Evangelos Liberopoulos; Fotios Barkas; Moses Elisaf
Journal:  World J Clin Cases       Date:  2014-10-16       Impact factor: 1.337

Review 5.  Clinical features of CKD-MBD in Japan: cohort studies and registry.

Authors:  Takayuki Hamano; Yusuke Sakaguchi; Naohiko Fujii; Yoshitaka Isaka
Journal:  Clin Exp Nephrol       Date:  2016-12-09       Impact factor: 2.801

6.  Serum magnesium, bone-mineral metabolism markers and their interactions with kidney function on subsequent risk of peripheral artery disease: the Atherosclerosis Risk in Communities Study.

Authors:  Steven Menez; Ning Ding; Morgan E Grams; Pamela L Lutsey; Gerardo Heiss; Aaron R Folsom; Elizabeth Selvin; Josef Coresh; Bernard G Jaar; Kunihiro Matsushita
Journal:  Nephrol Dial Transplant       Date:  2020-11-01       Impact factor: 5.992

7.  Associations of serum and urinary magnesium with the pre-diabetes, diabetes and diabetic complications in the Chinese Northeast population.

Authors:  Jiancheng Xu; Wei Xu; Hanxin Yao; Weixia Sun; Qi Zhou; Lu Cai
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

8.  Diabetes is the main factor accounting for hypomagnesemia in obese subjects.

Authors:  Albert Lecube; Juan Antonio Baena-Fustegueras; José Manuel Fort; Dolors Pelegrí; Cristina Hernández; Rafael Simó
Journal:  PLoS One       Date:  2012-01-24       Impact factor: 3.240

9.  Incidence of hyperglycemia and diabetes and association with electrolyte abnormalities in pediatric solid organ transplant recipients.

Authors:  Rahul Chanchlani; Sang Joseph Kim; Esther D Kim; Tonny Banh; Karlota Borges; Jovanka Vasilevska-Ristovska; Yanhong Li; Vicky Ng; Anne I Dipchand; Melinda Solomon; Diane Hebert; Rulan S Parekh
Journal:  Nephrol Dial Transplant       Date:  2017-09-01       Impact factor: 5.992

10.  Retrospective study of factors associated with progression and remission/regression of diabetic kidney disease-hypomagnesemia was associated with progression and elevated serum alanine aminotransferase levels were associated with remission or regression.

Authors:  Tatsuo Yanagawa; Keiko Koyano; Koichiro Azuma
Journal:  Diabetol Int       Date:  2021-01-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.